Anti-IL-5 therapies for asthma-Reference-Cited by-同舟云学术

Anti-IL-5 therapies for asthma

Published:2022-07-12 Issue:7 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Farne Hugo A¹,Wilson Amanda²,Milan Stephen³,Banchoff Emma⁴,Yang Freda⁵,Powell Colin VE⁶

Affiliation:

1. Imperial College; London UK

2. School of Nursing and Midwifery; University of Technology Sydney; Sydney Australia

3. Health Innovation Campus and Centre for Health Futures; Lancaster University; Lancaster UK

4. University of Michigan; Ann Arbor USA

5. Chelsea and Westminster Hospital NHS Foundation Trust; London UK

6. Department of Emergency Medicine; Sidra Medciine; Doha Qatar

Publisher

Wiley

Subject

Pharmacology (medical)

Reference455 articles.

1. Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials;Bernstein;Lancet Respiratory Medicine,2020

2. Study of reslizumab in patients with uncontrolled asthma and elevated blood eosinophils clinicaltrials.gov/show/NCT02452190

3. An efficacy and safety study of reslizumab subcutaneous in patients with oral corticosteroid dependent asthma and elevated blood eosinophils www.clinicaltrials.gov/ct2/show/NCT02501629

4. A randomized phase 3 study of the efficacy and safety of reslizumab in subjects with asthma with elevated eosinophils;Bjermer;European Respiratory Journal,2014

5. Reslizumab for inadequately controlled asthma with elevated blood eosinophil levels: a randomized phase 3 study;Bjermer;Chest,2016

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison and review of international guidelines for treating asthma in children;Clinical and Experimental Pediatrics;2024-09-15

2. Anti‐IL‐5 treatments are a useful adjunct for treatment of chronic severe asthma;Journal of Paediatrics and Child Health;2024-09-03

3. Valoración del recuento sanguíneo de eosinófilos en la patología respiratoria desde atención primaria;Medicina de Familia. SEMERGEN;2024-09

4. Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease;Cellular and Molecular Life Sciences;2024-08-17

5. The systemic treatments for drug reaction with eosinophilia and systemic symptoms (DRESS) beyond corticosteroids;World Allergy Organization Journal;2024-08